🇺🇸 FDA
Patent

US 11207396

Immunization to protect against adverse cardiac events relating to pneumococcal infection

granted A61KA61K2039/6037A61K2039/64

Quick answer

US patent 11207396 (Immunization to protect against adverse cardiac events relating to pneumococcal infection) held by The Board of Regents of the University of Texas System expires Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/6037, A61K2039/64, A61K39/092, A61K45/06